ASIA PACIFIC NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

ASIA PACIFIC NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

The Asia Pacific nasal spray devices market is expected to proliferate at a CAGR of 7.37% during the forecasting years of 2019-2027. Asia-Pacific nasal spray devices market will be on up-surging trend owing to the increase in the prevalence of asthma and other respiratory diseases along with the ongoing research and development activities for the development of generic nasal spray products.

ASIA PACIFIC NASAL SPRAY DEVICES MARKET FORECAST 2019-2027

Asia Pacific Nasal Spray Devices Market By Product (decongestion Nasal Spray, Saltwater, Solution/saline Nasal Spray, Steroid Nasal Spray) By Prescription (over-the-counter, Prescribed) By Therapeutic (antihistamine, Anticholinergic, Mast Cell Inhibitor, Nasal Steroids) By Application (allergic And Non-allergic Rhinitis, Cns Disorders, Nasal Congestion, Vaccination, Other Application) By End-user (asc/clinics, Home Care Setting, Hospital, Pharmacy, Other End-user) By Geography.

Request free sample

The nasal spray devices market deals with the adoption of devices that are used for the purpose of delivering drugs through the nose especially for patients severely affected by allergic rhinitis, non-allergic rhinitis, and nasal congestion. The therapeutically active ingredients present in the nasal sprays that are available in the solution, suspension, and other forms.

The Asia Pacific nasal spray devices market is expected to proliferate at a CAGR of 7.37% during the forecasting years of 2019-2027. Asia-Pacific nasal spray devices market will be on up-surging trend owing to the increase in the prevalence of asthma and other respiratory diseases along with the ongoing research and development activities for the development of generic nasal spray products. The major economies influencing the regional market are China, India, Japan, Australia, South Korea and the Rest of Asia Pacific.

The nasal spray devices market is segmented on the basis of product, prescription, therapeutic, application, and end-user. Various advantages of nasal spray devices are the avoidance of the first-pass metabolism, ease of administration and rapid onset of action. They also offer an alternative substitute for oral transmucosal, intravenous, oral or rectal administration in relieving pain with opioids. Hence, they are better adapted than other alternatives in the patient pool.

The manufacturers voluntarily recall their nasal spray products due to various incidences reported by the customers and their shared feedbacks for using the products. The various incidences of product recall reported recently by FDA or companies itself act as a restraining factor for global nasal spray devices market over the forecast period.

The major companies operating in the market that are mentioned in the report are Mylan NV, Becton Dickinson and Company, Adapt Pharma, Inc. (acquired by Emergent BioSolutions), Beximco Pharmaceuticals, Sanofi-Aventis S.A., Apotex, Sandoz International GmbH (subsidiary of Novartis AG), Hikma Pharmaceuticals PLC, Allergan Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., GlaxoSmithKline, Pfizer, Inc., Cipla and Sun Pharmaceuticals Industries, Ltd.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • DECONGESTION NASAL SPRAY HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • OVER THE COUNTER PRESCRIPTION IS ANTICIPATED TO GROW SIGNIFICANTLY
      • ANTIHISTAMINE IS THE FASTEST GROWING THERAPEUTICS
      • NASAL CONGESTION IS THE MAJORLY USED APPLICATION OF NASAL SPRAY DEVICES
      • HOME CARE SETTING IS THE FASTEST GROWING END-USER
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • SURGE IN INCIDENCE OF RESPIRATORY DISEASES
      • LOW COST OF GENERIC PRESCRIPTION DRUGS
    • MARKET RESTRAINTS
      • STRINGENT REGULATION
      • RISING INCIDENCES OF PRODUCT RECALL
    • MARKET OPPORTUNITIES
      • RISING ADOPTION OF GENERIC DRUGS
      • GROWING DEMAND OF NASAL DRUGS IN PHARMACEUTICAL MARKET
    • MARKET CHALLENGES
      • PATENT EXPIRATION
  1. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • SALTWATER SOLUTION/SALINE NASAL SPRAY
    • STEROID NASAL SPRAY
  2. MARKET BY PRESCRIPTION
    • OVER-THE-COUNTER
    • PRESCRIBED
  3. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
    • NASAL STEROIDS
  4. MARKET BY APPLICATION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • CNS DISORDERS
    • NASAL CONGESTION
    • VACCINATION
    • OTHER APPLICATION
  5. MARKET BY END-USER
    • ASC/CLINICS
    • HOME CARE SETTING
    • HOSPITAL
    • PHARMACY
    • OTHER END-USER
  6. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  7. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ADAPT PHARMA, INC. (ACQUIRED BY EMERGENT BIOSOLUTIONS)
        • COMPANY OVERVIEW
        • PRODUCT LAUNCH
        • STRATEGIC INITIATIVES
      • ALLERGAN INC.
        • COMPANY OVERVIEW
        • PRODUCT & SERVICES
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • APOTEX
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • BECTON DICKINSON AND COMPANY
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BEXIMCO PHARMACEUTICALS
        • COMPANY OVERVIEW
        • PRODUCT LAUNCH
        • STRATEGIC INITIATIVES
      • CIPLA
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HIKMA PHARMACEUTICALS PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • MERCK & CO., INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • MYLAN NV
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SANDOZ INTERNATIONAL GMBH (SUBSIDIARY OF NOVARTIS AG)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • SANOFI-AVENTIS S.A.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SUN PHARMACEUTICALS INDUSTRIES, LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES

 

TABLE LIST

TABLE 1        ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 2        ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 3        ASIA PACIFIC DECONGESTION NASAL SPRAY MARKET 2019-2027 ($ MILLION)

TABLE 4        ASIA PACIFIC SALT WATER SOLUTION/ SALINE NASAL SPRAY MARKET 2019-2027 ($ MILLION)

TABLE 5        ASIA PACIFIC STEROID NASAL SPRAY MARKET 2019-2027 ($ MILLION)

TABLE 6        ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)

TABLE 7        ASIA PACIFIC OVER THE COUNTER MARKET 2019-2027 ($ MILLION)

TABLE 8        ASIA PACIFIC PRESCRIBED MARKET 2019-2027 ($ MILLION)

TABLE 9        ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)

TABLE 10      ASIA PACIFIC ANTIHISTAMINE MARKET 2019-2027 ($ MILLION)

TABLE 11      ASIA PACIFIC ANTICHOLINERGIC MARKET 2019-2027 ($ MILLION)

TABLE 12      ASIA PACIFIC MAST CELL INHIBITOR MARKET 2019-2027 ($ MILLION)

TABLE 13      ASIA PACIFIC NASAL STEROIDS MARKET 2019-2027 ($ MILLION)

TABLE 14      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 15      ASIA PACIFIC ALLERGIC AND NON-ALLERGIC RHINITIS MARKET 2019-2027 ($ MILLION)

TABLE 16      ASIA PACIFIC CNS DISORDERS MARKET 2019-2027 ($ MILLION)

TABLE 17      ASIA PACIFIC NASAL CONGESTION MARKET 2019-2027 ($ MILLION)

TABLE 18      ASIA PACIFIC VACCINATION MARKET 2019-2027 ($ MILLION)

TABLE 19      ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)

TABLE 20      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 21      ASIA PACIFIC ASC/CLINICS MARKET 2019-2027 ($ MILLION)

TABLE 22      ASIA PACIFIC HOME CARE SETTING MARKET 2019-2027 ($ MILLION)

TABLE 23      ASIA PACIFIC HOSPITAL MARKET 2019-2027 ($ MILLION)

TABLE 24      ASIA PACIFIC PHARMACY MARKET 2019-2027 ($ MILLION)

TABLE 25      ASIA PACIFIC OTHER END-USER MARKET 2019-2027 ($ MILLION)

TABLE 26      ASIA PACIFIC ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURE LIST

FIGURE 1      ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 2      ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRODUCT 2018 & 2027 (%)

FIGURE 3      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY DECONGESTION NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 4      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY SALT WATER SOLUTION/ SALINE NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 5      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY STEROID NASAL SPRAY 2019-2027 ($ MILLION)

FIGURE 6      ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY PRESCRIPTION 2018 & 2027 (%)

FIGURE 7      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)

FIGURE 8      ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PRESCRIBED 2019-2027 ($ MILLION)

FIGURE 9      ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)

FIGURE 10   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTIHISTAMINE 2019-2027 ($ MILLION)

FIGURE 11   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ANTICHOLINERGIC 2019-2027 ($ MILLION)

FIGURE 12   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY MAST CELL INHIBITOR 2019-2027 ($ MILLION)

FIGURE 13   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL STEROIDS 2019-2027 ($ MILLION)

FIGURE 14   ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 15   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ALLERGIC AND NON-ALLERGIC RHINITIS 2019-2027 ($ MILLION)

FIGURE 16   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY CNS DISORDERS 2019-2027 ($ MILLION)

FIGURE 17   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY NASAL CONGESTION 2019-2027 ($ MILLION)

FIGURE 18   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY VACCINATION 2019-2027 ($ MILLION)

FIGURE 19   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)

FIGURE 20   ASIA PACIFIC NASAL SPRAY DEVICES MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 21   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY ASC/CLINICS 2019-2027 ($ MILLION)

FIGURE 22   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOME CARE SETTING 2019-2027 ($ MILLION)

FIGURE 23   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY HOSPITAL 2019-2027 ($ MILLION)

FIGURE 24   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY PHARMACY 2019-2027 ($ MILLION)

FIGURE 25   ASIA PACIFIC NASAL SPRAY DEVICES MARKET BY OTHER END-USER 2019-2027 ($ MILLION)

FIGURE 26   PORTER’S FIVE FORCE MODEL

FIGURE 27   KEY BUYING CRITERIA

FIGURE 28   ASIA PACIFIC NASAL SPRAY DEVICES SUPPLY CHAIN ANALYSIS

FIGURE 29   ASIA PACIFIC NASAL SPRAY DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 30   CHINA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 31   INDIA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 32   JAPAN ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 33   AUSTRALIA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 34   SOUTH KOREA NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 35   REST OF ASIA PACIFIC NASAL SPRAY DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 36   NASAL SPRAY DEVICES COMPANY MARKET SHARE 2017 (%)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • SALTWATER SOLUTION/SALINE NASAL SPRAY
    • STEROID NASAL SPRAY
  2. MARKET BY PRESCRIPTION
    • OVER-THE-COUNTER
    • PRESCRIBED
  3. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
    • NASAL STEROIDS
  4. MARKET BY APPLICATION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • CNS DISORDERS
    • NASAL CONGESTION
    • VACCINATION
    • OTHER APPLICATION
  5. MARKET BY END-USER
    • ASC/CLINICS
    • HOME CARE SETTING
    • HOSPITAL
    • PHARMACY
    • OTHER END-USER

 

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now